Elevation of ADAM10, ADAM17, MMP-2 and MMP-9 expression with media degeneration features CaCl2-induced thoracic aortic aneurysm in a rat model

Experimental and Molecular Pathology

Volumn 89, Issue 1, 2010, Pages 72-81

  Geng, L ^a   Wang, W ^a   Chen, Y ^a   Cao, J ^a   Lu, L ^a   Chen, Q ^a   He, R ^a   Shen, W ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

A disintegrin and metalloproteinase; Matrix metalloproteinase; Thoracic aortic aneurysm; Tissue inhibitor of metalloproteinase

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; CALCIUM CHLORIDE; CD68 ANTIGEN; COLLAGEN; GELATINASE A; GELATINASE B; MESSENGER RNA; PROTEIN ADAM17; SODIUM CHLORIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; ELASTIC FIBER; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE; MALE; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; THORACIC AORTA ANEURYSM;

ADAM PROTEINS; ANIMALS; AORTIC ANEURYSM, THORACIC; CALCIUM CHLORIDE; COLLAGEN; DISEASE MODELS, ANIMAL; IMMUNOENZYME TECHNIQUES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

ANIMALIA; RATTUS;

EID: 77954032484     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.05.006     Document Type: Article

References (31)

1. Amour A., Knight C.G., Webster A., Slocombe P.M., Stephens P.E., Knauper V., Docherty A.J., Murphy G. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS. Lett. 2000, 473:275-279.
2. Barbour J.R., Spinale F.G., Ikonomidis J.S. Proteinase systems and thoracic aortic aneurysm progression. J. Surg. Res. 2007, 139:292-307.
3. Basalyga D.M., Simionescu D.T., Xiong W., Baxter B.T., Starcher B.C., Vyavahare N.R. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation 2004, 110:3480-3487.
4. Cho A., Graves J., Reidy M.A. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb. Vasc. Biol. 2000, 20:2527-2532.
5. Collins M.J., Dev V., Strauss B.H., Fedak P.W., Butany J. Variation in the histopathological features of patients with ascending aortic aneurysms: a study of 111 surgically excised cases. J. Clin. Pathol. 2008, 61:519-523.
6. Deschamps A.M., Spinale F.G. Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation. Cardiovasc. Res. 2006, 69:666-676.
7. Eaton V.L., Lerret N.M., Velasquez-Lopera M.M., John R., Caicedo M., DeCresce R.P., Jaramillo A. Enhanced allograft survival and modulation of T-cell alloreactivity induced by inhibition of MMP/ADAM enzymatic activity. Am. J. Transplant. 2008, 8:507-516.
8. Elefleriades J.A. Thoracic aortic aneurysm: reading the enemy's playbook., 2008. Current Problems in Cardiology 2008, 33:203-277.
9. Freestone T., Turner R.J., Higman D.J., Lever M.J., Powell J.T. Influence of hypercholesterolemia and adventitial inflammation on the development of aortic aneurysm in rabbits. Arterioscler. Thromb. Vasc. Biol 1997, 17:10-17.
10. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 2002, 90:251-262.
11. Gertz S.D., Kurgan A., Eisenberg D. Aneurysm of the rabbit common carotid artery induced by periarterial application of calcium chloride in vivo. J. Clin. Invest. 1988, 81:649-656.
12. He R., Guo D.C., Sun W., Papke C.L., Duraisamy S., Estrera A.L., Safi H.J., Ahn C., Buja L.M., Arnett F.C., Zhang J., Geng Y.J., Milewicz D.M. Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms. J. Thorac. Cardiavasc. Surg. 2008, 136:922-929. 929 e1.
13. Ikonomidis J.S., Gibson W.C., Gardner J., Sweterlitsch S., Thompson R.P., Mukherjee R., Spinale F.G. A murine model of thoracic aortic aneurysms. J. Surg. Res. 2003, 115:157-163.
14. Ikonomidis J.S., Jones J.A., Barbour J.R., Stroud R.E., Clark L.L., Kaplan B.S., Zeeshan A., Bavaria J.E., Gorman J.H., Spinale F.G., Gorman R.C. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves. J. Thorac. Cardiavasc. Surg. 2007, 133:1028-1036.
15. Lliopoulos D.C., Kritharis E.P., Giagini A.T., Papadodima S.A., Sokodis D.P. Ascending thoracic aortic aneurysms are associated with compositional remodeling and vessel stiffening but not weakening in age-matched subjects. J. Thorac. Cardiavasc. Surg. 2009, 137:101-109.
16. Ince H., Nienaber C.A. Etiology, pathogenesis and management of thoracic aortic aneurysm. Nat. Clin. Pract. Cardiovasc. Med. 2007, 4:418-427.
17. Koullias G.J., Ravichandran P., Korkolis D.P., Rimm D.L., Elefteriades J.A. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann. Thorac. Surg. 2004, 78:2106-2110.
18. Lehoux S., Lemarié C.A., Esposito B., Lijnen H.R., Tedgui A. Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling. Circulation 2004, 109:1041-1047.
19. Lesauskaite V., Epistolato M.C., Castagnini M., Urbonavicius S., Tanganelli P. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology. Hum. Pathol. 2006, 37:1076-1084.
20. Longo G.M., Buda S.J., Fiotta N., Xiong W., Griener T., Shapiro S., Baxter B.T. MMP-12 has a role in abdominal aortic aneurysms in mice. Surgery 2005, 137:457-462.
21. Longo G.M., Xiong W., Greiner T.C., Zhao Y., Fiotti N., Baxter B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 2002, 110:625-632.
22. Pagano M.B., Zhou H.F., Ennis T.L., Wu X., Lambris J.D., Atkinson J.P., Thompson R.W., Hourcade D.E., Pham C.T. Complement-dependent neutrophil recruitment is critical for the development of elastase-induced abdominal aortic aneurysm. Circulation 2009, 119:1805-1813.
23. Pruessmeyer J., Ludwig A. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Semin. Cell. Dev. Biol. 2009, 20:164-174.
24. Raffetto J.D., Khalil R.A. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem. Pharmacol. 2008, 75:346-359.
25. Satoh M., Nakamura M., Saitoh H., Satoh H., Maesawa C., Segawa I., Tashiro A., Hiramori K. Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy. Circulation 1999, 99:3260-3265.
26. Satta J., Haukipuro K., Kairaluoma M.I., Juvonen T. Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms. J. Vasc. Surg. 1997, 25:909-915.
27. Satta J., Juvonen T., Haukipuro K., Juvonen M., Kairaluoma M.I. Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples. J. Vasc. Surg. 1995, 22:155-160.
28. Taketani T., Imai Y., Morota T., Maemura K., Morita H., Hayashi D., Yamazaki T., Nagai R., Takamoto S. Altered patterns of gene expression specific to thoracic aortic aneurysms: microarray analysis of surgically resected specimens. Int. Heart. J. 2005, 46:265-277.
29. Tchougounova E., Lundequist A., Fajardo I., Winberg J.O., Abrink M., Pejle G. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 2005, 280:9291-9296.
30. Wang X., LeMaire S.A., Chen L., Shen Y.H., Gan Y., Bartsch H., Carter S.A., Utama B., Ou H., Coselli J.S., Wang X.L. Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection. Circulation 2006, 114:I200-I205.
31. Wang X., Oka T., Chow F.L., Cooper S.B., Odenbach J., Lopaschuk G.D., Kassiri Z., Fernandez-Patron C. Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis. Hypertension 2009, 54:575-582.